Heart Failure

P139 - A DISCRETE CHOICE EXPERIMENT OF THE MEDICATION PREFERENCES OF PATIENTS WITH HEART FAILURE

P140 - ASSOCIATION BETWEEN DISCHARGE TIMING AND DISCHARGE QUALITY AND DISPOSITION IN ACUTE HEART FAILURE

P141 - ASSOCIATIONS BETWEEN WRIST-WORN ACCELEROMETRY BIOMARKERS AND MORTALITY IN HEART FAILURE

P142 - CHANGING HEMODYNAMIC INDICATIONS FOR A VASODILATOR CHALLENGE DURING THE ASSESSMENT OF PULMONARY HYPERTENSION IN ADVANCED HEART FAILURE

P143 - CHASING ZEBRAS: HYDROXYCHLOROQUINE-INDUCED CARDIOMYOPATHY MIMICKING TRANSTHYRETIN CARDIAC AMYLOIDOSIS

P144 - CRITICAL RESOURCES USE IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE WITHOUT CARDIOGENIC SHOCK ADMITTED TO CARDIAC INTENSIVE CARE UNIT

P145 - DESMOPLAKIN CARDIOMYOPATHY PRESENTING AS RECURRENT MYOCARDITIS: A NOVEL TRUNCATING VARIANT AND PROPOSED TREATMENT ALGORITHM

P146 - DESTINATION THERAPY LEFT VENTRICULAR ASSIST DEVICES: A 20-YEAR CANADIAN SINGLE-CENTRE EXPERIENCE

P147 - DYSTROPHIN-DEFICIENT CARDIOMYOPATHY DUE TO A NOVEL HEMIZYGOUS DMD INDEL VARIANT

P148 - EARLY CLINICAL MANIFESTATIONS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY

P149 - EARLY DETECTION, EQUITABLE CARE: PILOTING A HEART FAILURE SCREENING PATHWAY IN FIRST NATIONS COMMUNITIES IN NORTHERN ONTARIO

P150 - EFFECT OF PEAK FLOW TRIGGERED ADAPTIVE SERVO-VENTILATION (ASVPF) ON MORTALITY IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS WITH PROLONGED CHEYNE-STOKES RESPIRATORY CYCLE LENGTH.

P151 - EFFECTS OF IVABRADINE ON HEART RATE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION UNDERGOING CHRONIC HEMODIALYSIS

P152 - EVALUATION OF HEMODYNAMIC CRITERIA FOR VASODILATOR CHALLENGE IN PULMONARY HYPERTENSION WITH ADVANCED HEART FAILURE: A PROSPECTIVE STUDY OF CLINICAL AND RIGHT HEART FAILURE OUTCOMES

P153 - EXAMINING THE ASSOCIATION BETWEEN SERIOUS ARRHYTHMIA AND INCREASED 30-DAY MORTALITY IN PATIENTS WITH FULMINANT MYOCARDITIS ON VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGEN

P154 - FULMINANT MYOCARDITIS IN ULCERATIVE COLITIS: DIVERGENT DIAGNOSES WITH A SHARED TRAJECTORY THROUGH SHOCK TO SURVIVAL

P156 - IMPACT OF A MULTIFACETED QUALITY IMPROVEMENT INITIATIVE ON ACCELERATING DETECTION, DIAGNOSIS, AND MANAGEMENT OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS

P157 - IMPACT OF ADMISSION TIMING ON MANAGEMENT AND IN-HOSPITAL OUTCOMES IN ACUTE HEART FAILURE: INSIGHTS FROM THE CAN-HF REGISTRY

P158 - IMPROVING OUTCOMES IN HEART FAILURE: HOW A COMPREHENSIVE TRANSITIONAL CARE PROGRAM DECREASES HOSPITAL READMISSIONS AND EMERGENCY DEPARTMENT UTILIZATION

P159 - INDIVIDUAL VS POOLED FOLLOW-UP IN A MULTIDISCIPLINARY HEART FAILURE CLINIC

P160 - INTERLEUKIN-17, INTERLEUKIN-18, T REGULATORY CELLS AND T-HELPER 17 (TH17) CELLS PLAY A ROLE IN HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

P161 - LEVERAGING LARGE AND DIVERSE BIOBANKS TO INVESTIGATE GENE-DISEASE ASSOCIATIONS FOR HYPERTROPHIC CARDIOMYOPATHY IMPLICATED GENES

P162 - NEURODEGENERATIVE BIOMARKERS AND HEART FAILURE: IS THERE A NEURODEGENERATIVE CARDIOMYOPATHY? A SYSTEMATIC REVIEW AND META-ANALYSIS

P163 - NEUROPSYCHOLOGICAL PROFILE THROUGH REMOTE ASSESSMENT IN CHRONIC HEART FAILURE

P164 - OPTIMIZATION OF GUIDELINE-DIRECTED MEDICAL THERAPY DURING HOSPITALIZATION FOR PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

P165 - PLASMA PROTEOMIC PROFILING REVEALS GENERAL AND ETIOLOGY-SPECIFIC BIOMARKERS FOR PRECISION DIAGNOSIS OF DILATED CARDIOMYOPATHY

P166 - PROGNOSTIC VALUE OF CIRCULATING LONG NON-CODING RNAS IN HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

P167 - PULMONARY VASCULAR HEMODYNAMICS IN LVAD PATIENTS: A COMPARATIVE ANALYSIS WITH HEALTHY CONTROLS AND IMPACT ON HEART TRANSPLANT OUTCOMES

P168 - REDUCING HOSPITAL STAY IN PATIENTS WITH DECOMPENSATED HEART FAILURE: A QUALITY IMPROVEMENT PROJECT

P169 - RELATIONSHIP BETWEEN CARDIORESPIRATORY FITNESS, CEREBROVASCULAR STIFFNESS, RESISTANCE AND COGNITIVE PERFORMANCE IN PATIENTS WITH HEART FAILURE

P170 - SCREENING FOR CARDIAC DISEASE AND EARLY INITIATION OF CARDIOPROTECTIVE THERAPIES IN LGMD R9 PATIENTS

P171 - SCREENING FOR DEPRESSION, OBSTRUCTIVE SLEEP APNEA, AND COGNITIVE IMPAIRMENT TO PREDICT ADVERSE OUTCOMES IN HEART FAILURE PATIENTS: THE CARDIACDOC PROSPECTIVE COHORT STUDY

P172 - SEVERE HYPERTROPHIC CARDIOMYOPATHY IN PREGNANCY: THE IMPORTANCE OF MULTIDISCIPLINARY APPROACH AND PREPARATION

P173 - SEX SPECIFIC COMPARISON OF ACUTE HEART FAILURE PRESENTATION IN THE EMERGENCY DEPARTMENT: BASELINE CHARACTERISTICS OF THE SEX SUBSTUDY OF THE COACH TRIAL

P174 - SEX-BASED DIFFERENCES IN CLINICAL PRESENTATION OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS: A COMPARATIVE ANALYSIS OF REFERRED AND SCREENED POPULATIONS

P175 - SHOCKING CONSISTENCY: NO WEEKEND EFFECT IN CARDIOGENIC SHOCK OUTCOMES

P177 - THE ASSOCIATION BETWEEN TRICUSPID REGURGITATION AND CLINICAL OUTCOMES IN PATIENTS WITH CARDIAC AMYLOIDOSIS

P178 - THE CANADIAN REGISTRY FOR AMYLOIDOSIS RESEARCH: A NATIONAL REGISTRY FOR REAL-WORLD EVIDENCE

P179 - THE EFFECT OF KETONE THERAPY IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW

P180 - THE IMPACT OF POINT OF CARE TESTING ON CLINICAL DECISION MAKING IN PATIENTS WITH HEART FAILURE IN THE AMBULATORY SETTING

P181 - THREE-YEAR OUTCOMES FROM A PROSPECTIVE REGISTRY OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY

P182 - TREATMENT PRACTICES IN HEART FAILURE WITH REDUCED EJECTION FRACTION BY SPECIALTY: AN ANALYSIS FROM THE VANCOUVER COASTAL ACUTE HEART FAILURE (VOCAL-AHF) REGISTRY

P183 - VESSEL-RESIDENT PROGENITORS MEDIATE HEART FAILURE WITH PRESERVED EJECTION FRACTION IN MICE

P184 - WHAT IS THE MEANING OF MAXIMALLY TOLERATED GUIDELINE-DIRECTED MEDICAL THERAPY IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES? INSIGHTS FROM A CANADIAN TERTIARY CENTRE

P366 - ECHOCARDIOGRAM QUALITY IMPROVEMENT PROJECT (EQUIP): INTEGRATING A RECOMMENDATION ENGINE FOR ATTR-CM DIAGNOSIS